A Study on Aspartate Platelet Ratio Index (APRI) Versus Splenic Bipolar Diameter Ratio in Predicting Oesophageal Varices in Patients with Cirrhosis in a Rural Medical College Hospital
Authors/Creators
- 1. Associate Professor of General Medicine, Government Theni Medical College and Hospital, Theni, Tamil Nadu-625512
- 2. Assistant Professor of General Medicine, Government Theni Medical College and Hospital, Theni, Tamil Nadu-625512
- 3. Scientist B, Department of Microbiology-VRDL, Government Theni Medical College and Hospital, Theni, Tamil Nadu-625512
Description
Cirrhosis presents a significant health burden globally, often leading to morbidity and premature mortality. Esophageal varices, a complication of cirrhosis, necessitate early identification to prevent potential bleeding complications. This prospective study, conducted at Government Medical College Hospital, Theni, aimed to evaluate non-invasive diagnostic markers for esophageal varices in cirrhotic patients. 75 patients diagnosed with liver cirrhosis were included after obtaining consent and meeting specific criteria. The study focused on assessing the utility of Aspartate Platelet Ratio Index (APRI) and Platelet Count to Splenic Diameter ratio in diagnosing esophageal varices. Statistical analyses were conducted using SPSS 1.0.0.1406, employing descriptive statistics, Chi-square, student t-tests, and ROC curves. The majority of the patients (89%) were male, predominantly in the age group of 50 to 60 years. Alcoholism was a prevalent etiology (89.33%) among the study cohort. Parameters such as platelet count, splenic diameter, and their ratio exhibited significant associations with the presence of esophageal varices. Notably, the Platelet Count to Splenic Diameter ratio demonstrated higher sensitivity (96%) and specificity (90.48%) in predicting esophageal varices compared to APRI. A cut-off value of <909 for this ratio exhibited robust positive and negative predictive values (88.8% and 90.4% respectively), indicating its potential as a reliable non-invasive marker for identifying esophageal varices. The study underscores the promising utility of the Platelet Count to Splenic Diameter ratio as a non-invasive parameter for diagnosing esophageal varices in cirrhotic patients. Validation of these findings in larger, multi-center studies could potentially reduce the necessity for invasive endoscopic procedures and aid in early identification and management of at-risk patients.
Abstract (English)
Cirrhosis presents a significant health burden globally, often leading to morbidity and premature mortality. Esophageal varices, a complication of cirrhosis, necessitate early identification to prevent potential bleeding complications. This prospective study, conducted at Government Medical College Hospital, Theni, aimed to evaluate non-invasive diagnostic markers for esophageal varices in cirrhotic patients. 75 patients diagnosed with liver cirrhosis were included after obtaining consent and meeting specific criteria. The study focused on assessing the utility of Aspartate Platelet Ratio Index (APRI) and Platelet Count to Splenic Diameter ratio in diagnosing esophageal varices. Statistical analyses were conducted using SPSS 1.0.0.1406, employing descriptive statistics, Chi-square, student t-tests, and ROC curves. The majority of the patients (89%) were male, predominantly in the age group of 50 to 60 years. Alcoholism was a prevalent etiology (89.33%) among the study cohort. Parameters such as platelet count, splenic diameter, and their ratio exhibited significant associations with the presence of esophageal varices. Notably, the Platelet Count to Splenic Diameter ratio demonstrated higher sensitivity (96%) and specificity (90.48%) in predicting esophageal varices compared to APRI. A cut-off value of <909 for this ratio exhibited robust positive and negative predictive values (88.8% and 90.4% respectively), indicating its potential as a reliable non-invasive marker for identifying esophageal varices. The study underscores the promising utility of the Platelet Count to Splenic Diameter ratio as a non-invasive parameter for diagnosing esophageal varices in cirrhotic patients. Validation of these findings in larger, multi-center studies could potentially reduce the necessity for invasive endoscopic procedures and aid in early identification and management of at-risk patients.
Files
IJPCR,Vol15,Issue12,Article144.pdf
Files
(529.5 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:ef5272e7e329d350eb77bc15d4f9ae9e
|
529.5 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-11-30
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue12,Article144.pdf
- Development Status
- Active
References
- 1. Moon AM, Singal AG, Tapper EB. Contemporary epidemiology of chronic liver disease and cirrhosis. Clinical Gastroenterology and Hepatology. 2020 Nov 1; 18(12):2650-66. 2. Olave MC, Gurung A, Mistry PK, Kakar S, Yeh M, Xu M, Wu TT, Torbenson M, Jain D. Etiology of cirrhosis in the young. Human pathology. 2020 Feb 1; 96:96-103. 3. Razavi H. Global epidemiology of viral hepatitis. Gastroenterology Clinics. 2020 Jun 1; 49(2):179-89. 4. Duah A, Nkrumah KN, Tachi K. Oesophagealvarices in patients with liver cirrhosis attending a major tertiary hospital in Ghana. Pan African Medical Journal. 2018 Dec 13; 31(1). 5. Kovalak M, Lake J, Mattek N, Eisen G, Lieberman D, Zaman A. Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database. Gastrointestinal endoscopy. 2007 Jan 1; 65(1):82-8. 6. Fernandez J, Aracil C, Sola E, Soriano G, Cardona MC, Coll S, Genesca J, Hombrados M, Morillas R, Martin-Llahi M, Pardo A. Evaluation and treatment of the critically ill cirrhotic patient. Gastroenterología y Hepatología (English Edition). 2016 Nov 1; 39(9):607-26. 7. Shaheen AA, Myers RP. Diagnostic accuracy of the aspartate aminotransferase‐to‐platelet ratio index for the prediction of hepatitis C– related fibrosis: A systematic review. Hepatology. 2007 Sep; 46(3):912-21. 8. Zhang W, Wang L, Wang L, Li G, Huang A, Yin P, Yang Z, Ling C, Wang L. Liver stiffness measurement, better than APRI, Fibroindex, Fib-4, and NBI gastroscopy, predicts portal hypertension in patients with cirrhosis. Cell BiochemBiophys. 2015; 71:865- 873. 9. Elalfy H, Elsherbiny W, Rahman AA, Elhammady D, Shaltout SW, Elsamanoudy AZ, El Deek B. Diagnostic non-invasive model of large risky esophageal varices in cirrhotic hepatitis C virus patients. World journal of hepatology. 2016 Aug 8; 8(24):1028. 10. Jensen DM. Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes.Gastroenterology. 2002; 122:1620- 1630. 11. Bosch J, Abraldes JG, Berzigotti A, GarciaPagan JC. Portal hypertension and gastrointestinal bleeding. Semin Liver Dis. 2008; 28:3-25. 12. deFranchis R. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015; 63:743-752. 13. deFranchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010; 53:762-768. 14. Sanyal AJ, Fontana RJ, Di Bisceglie AM, Everhart JE, Doherty MC, Everson GT, Donovan JA, Malet PF, Mehta S, Sheikh MY, Reid AE. The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis. Gastrointestinal Endoscopy. 2006 Dec 1; 64(6):855-64. 15. Berzigotti A, Gilabert R, Abraldes JG, Nicolau C, Bru C, Bosch J, García-Pagan JC. Noninvasive prediction of clinically significant portal hypertension and esophageal varices in patients with compensated liver cirrhosis. Official journal of the American College of Gastroenterology| ACG. 2008 May 1; 103(5):1159-67. 16. Castéra L, Le Bail B, Roudot-Thoraval F, Bernard PH, Foucher J, Merrouche W, Couzigou P, de Lédinghen V. Early detection in routine clinical practice of cirrhosis andoesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. Journal of hepatology. 2009 Jan 1; 50(1):59-68